Actively Recruiting

Age: 18Years +
All Genders
ID07500376

Prognostic Value of Multimodal Nutritional Status and Sarcopenia Assessment for Postoperative Risk Stratification in Patients Undergoing Lung Cancer Surgery: A Prospective Cohort Study

Led by Ondokuz Mayıs University · Updated on 2026-03-30

142

Participants Needed

1

Research Sites

8 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are studying how combined assessments of nutritional status and muscle loss (sarcopenia) can predict outcomes for adults undergoing lung cancer surgery. Malnutrition and sarcopenia are known to affect recovery, but their joint impact has not been fully explored. This observational study aims to improve risk prediction and support personalized care before and after surgery for patients with primary lung cancer. Participants will have their nutritional health evaluated through blood tests for proteins and inflammatory markers, clinical nutrition scores, and physical tests like handgrip strength. Muscle loss will be measured using CT scans and ultrasound of chest muscles taken within 30 days before surgery. All patients will undergo anatomical lung resections such as lobectomy or segmentectomy, and no experimental treatments will be given as part of the study. After surgery, researchers will track complications, need for intensive care, hospital stay duration, and short-term mortality using standard grading systems. Statistical analyses will identify factors independently linked to poor outcomes and develop a combined risk model. This long-term observational study aims to provide practical tools to help tailor nutritional and rehabilitation strategies in lung cancer surgery patients.

CONDITIONS

Brief Title

Multimodal Nutritional and Sarcopenia Assessment for Risk Stratification in Lung Cancer Surgery

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 years or older
  • Patients undergoing anatomical lung resection (lobectomy or segmentectomy) for primary lung cancer
  • Availability of preoperative thoracic computed tomography (CT) within 30 days before surgery
  • Completion of preoperative nutritional assessment and ultrasonographic muscle measurements
  • Ability to provide written informed consent
Not Eligible

You will not qualify if you...

  • Receipt of neoadjuvant chemotherapy, immunotherapy, or radiotherapy
  • Emergency surgery
  • Pneumonectomy
  • Combined resection of another organ during the same procedure
  • Inadequate or non-evaluable imaging or measurement data
  • Immunosuppressive therapy or presence of advanced/metastatic disease
  • Significant thoracic deformity or prior conditions interfering with muscle measurements
  • Refusal or inability to provide informed consent

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

Diagnostic Evaluation

Duration - Up to 30 days before surgery

Participants undergo preoperative assessments including nutritional status evaluation through laboratory measurements, clinical nutritional scores, bioimpedance analysis, handgrip strength, functional tests, and imaging-based sarcopenia assessment using CT and ultrasound.

1 to 2 visits as part of routine care

Surgery and Immediate Post-operative Care

Duration - Hospital stay up to 30 days

Participants undergo anatomical lung resection surgery and receive immediate postoperative care during hospitalization.

Hospitalization period with daily monitoring

Post-operative Follow-up

Duration - 30 days after surgery

Participants are observed for postoperative outcomes including complications, intensive care unit requirement, length of hospital stay, and short-term mortality.

Follow-up visits or assessments during 30 days post-surgery

Trial Site Locations

Total: 1 location

1

Ondokuz Mayis University Faculty of Medicine, Department of Thoracic Surgery

Samsun, Samsun, Turkey (Türkiye)

Actively Recruiting

Loading map...

Research Team

C

Caner İşevi, MD

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Similar Trials

A Phase II Study to Evaluate the Safety and Efficacy of SKB5...

Lung Cancer (Non-Small Cell)

Actively Recruiting

2 locations

A Multicenter, Randomized, Double-Blind, Placebo-controlled ...

Sarcopenia in Elderly

Actively Recruiting

4 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here